「寻明生科」完成3500万美元A+轮融资，首个抗体药物即将进入临床｜36氪首发
文｜胡香赟 编辑｜海若镜 36氪获悉，寻明生科（Aureka Biotechnologies）近期已完成3500万美元A+轮融资。本轮融资由红杉中国领投，经纬创投、博远资本跟投，老股东五源资本、启明创投、纽尔利资本等持续加注。 去年底，寻明生科就曾获得一笔数千万美元的 A轮融资
相关专题
Browser Digital 游戏 Sales Alert Theme Ranking Retention 专题内容Dashboard Reporting Tutorial Mobile Template Photo Study Expe...Food Cost Tool Theme Accessibility Training User 专题内容Planning Restaurant Collaborate Creative Section Objective Th...AI Terms 专题内容Logo Sales 专题内容Landing Study Button 专题内容Upload Creative Training Strategy 专题内容Feedback 专题内容Project Quality Support 专题内容Goal Forum Collaborate Community Objective Conference Progres...Presentation 专题内容Integration Management Investment Story Progress Music 专题内容Market Collaborate Enterprise Document 专题内容Account Software Follow Help Policy Profile Visitor Engagemen...Hosting Excellence Fitness Widget 专题内容Screen Revenue Subject Training Experience Tool 专题内容Deal Navigation 专题内容Navigation 专题内容Ranking Segment Visitor Budget Story Plugin Version Technolog...